PURI-NETHOL mercaptopurine monohydrate 50mg tablet bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

puri-nethol mercaptopurine monohydrate 50mg tablet bottle

aspen pharmacare australia pty ltd - mercaptopurine monohydrate, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch - indications as at 5 march 2004: treatment of leukemia. it is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. puri-nethol is also used in the treatment of chronic granulocytic leukaemia.

Puri-Nethol 50 mg Tablet Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

puri-nethol 50 mg tablet

pi pharma - mercaptopurine - tablet - 50 mg - mercaptopurine 50 mg - mercaptopurine

PURI-NETHOL TABLETS 50 MG Israel - Inggris - Ministry of Health

puri-nethol tablets 50 mg

padagis israel agencies ltd, israel - mercaptopurine - tablets - mercaptopurine 50 mg - mercaptopurine - mercaptopurine - for the treatment of acute leukemia and also in cases of chronic myelogenous leukemia.

Puri-Nethol 50 mg tabl. Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

puri-nethol 50 mg tabl.

aspen pharma trading ltd. - mercaptopurine 50 mg - tablet - 50 mg - mercaptopurine 50 mg - mercaptopurine

Puri-Nethol 50mg Tablets Malta - Inggris - Medicines Authority

puri-nethol 50mg tablets

aspen pharma trading limited 3016 lake drive city west businees campus dublin 24, ireland - mercaptopurine - tablet - mercaptopurine 50 mg - antineoplastic agents